Greg Anderson BSc, MSc, PhD
Greg Anderson is based at the QIMR Berghofer Medical Research Institute in Brisbane where he is Head of the Chronic Disorders Program, Head of the Iron Metabolism Laboratory and a Principal Research Fellow. He has adjunct appointments in the Schools of Chemistry and Molecular Biosciences, and Medicine at the University of Queensland and is a Visiting Professor at the National Center for Nanoscience and Technology in Beijing. After a PhD at the University of Queensland, he conducted postdoctoral work at the US National Institutes of Health. He has worked in the area of iron homeostasis for over 30 years, and also has research interests in gastrointestinal and liver disease, and nanotechnology-based drug delivery platforms. Particular areas of focus include mechanisms of intestinal iron absorption, the pathogenesis of iron loading diseases, the use of nanotechnology for modulating body iron levels and for cancer therapy, iron homeostasis in early postnatal life, and mechanisms of hepatic encephalopathy. He has published over 200 papers. He is a former President of the International BioIron Society, serves on the Board of the International Biometals Society and served on the Research Committee of the Gastroenterological Society of Australia for 10 years.
(Sun 08:30-10:45 Elston Room) Session 3: Liver - Inflammation & Modifiers of Injury
(09:00-09:15) Presentation Title TBA
(back to speakers)
|
.jpg)